[SINA Reports Fourth Quarter and Fiscal Year 2018 Unaudited Financial Results BEIJING, ChinaMarch 5, 2019 Fourth Quarter 2018 Highlights · · · · · · Fiscal Year 2018 Highlights · · · · Fourth Quarter 2018 Financial Results For the fourth quarter of 2018, SINA reported net revenues of $573.0 million]
[SINA Reports Fourth Quarter and Fiscal Year 2018 Unaudited Financial Results BEIJING, ChinaMarch 5, 2019 Fourth Quarter 2018 Highlights · · · · · · Fiscal Year 2018 Highlights · · · · Fourth Quarter 2018 Financial Results For the fourth quarter of 2018, SINA reported net revenues of $573.0 million]
[www.umc.com Description 99.1 Announcement on 2019/03/06: Important Resolutions from 14th term 7th Board Meeting 99.2 Announcement on 2019/03/06: Board Meeting Resolution on dividend distribution 99.3 Announcement on 2019/03/06: Announcing termination of private equity offering which was approved by ]
[www.umc.com Description 99.1 Announcement on 2019/03/06: Important Resolutions from 14th term 7th Board Meeting 99.2 Announcement on 2019/03/06: Board Meeting Resolution on dividend distribution 99.3 Announcement on 2019/03/06: Announcing termination of private equity offering which was approved by ]
[Weibo Reports Fourth Quarter and Fiscal Year 2018 Unaudited Financial Results BEIJING, China March 5, 2019 Weibo Corporation (Weibo or the Company) (NASDAQ: WB), a leading social media in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended Dece]
[Weibo Reports Fourth Quarter and Fiscal Year 2018 Unaudited Financial Results BEIJING, China March 5, 2019 Weibo Corporation (Weibo or the Company) (NASDAQ: WB), a leading social media in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended Dece]
[FOR RELEASE March 6, 2019 China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2018 --4Q18 Total Sales Up 27.5% YoY in USD terms, or 33.5% YoY in RMB terms; --FY18 Total Sales Up 26.1% YoY in USD terms, or 23.5% YoY in RMB terms; -- Issues Forecast for FY19 – --Board of Di]
[FOR RELEASE March 6, 2019 China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2018 --4Q18 Total Sales Up 27.5% YoY in USD terms, or 33.5% YoY in RMB terms; --FY18 Total Sales Up 26.1% YoY in USD terms, or 23.5% YoY in RMB terms; -- Issues Forecast for FY19 – --Board of Di]
